{
    "clinical_study": {
        "@rank": "47108", 
        "brief_summary": {
            "textblock": "To compare the safety and efficacy of aerosolized pentamidine and dapsone in the prevention\n      of Pneumocystis carinii pneumonia (PCP) in high-risk HIV-infected patients who are\n      intolerant to trimethoprim and/or sulfonamides.\n\n      Both aerosolized pentamidine and dapsone have been shown to prevent PCP, but both drugs\n      cause side effects. This study attempts to determine which drug is more efficacious as\n      prophylaxis against PCP in patients who cannot tolerate trimethoprim/sulfamethoxazole."
        }, 
        "brief_title": "A Study of Pentamidine Plus Dapsone in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients Who Cannot Take Trimethoprim or Sulfonamides", 
        "completion_date": {
            "#text": "June 1994", 
            "@type": "Actual"
        }, 
        "condition": [
            "Pneumonia, Pneumocystis Carinii", 
            "HIV Infections"
        ], 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome", 
                "Pneumonia", 
                "Pneumonia, Pneumocystis"
            ]
        }, 
        "detailed_description": {
            "textblock": "Both aerosolized pentamidine and dapsone have been shown to prevent PCP, but both drugs\n      cause side effects. This study attempts to determine which drug is more efficacious as\n      prophylaxis against PCP in patients who cannot tolerate trimethoprim/sulfamethoxazole.\n\n      Patients are evenly divided between two treatment arms to receive either aerosolized\n      pentamidine every 4 weeks or dapsone orally three times weekly. Follow-up data is collected\n      every 3 months, and patients are clinically evaluated every 6 months. Patients who develop\n      PCP or a severe or persistent study drug toxicity may be switched to the alternative study\n      drug at the clinician's discretion. Average duration of follow-up is 2 years."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Patients must have:\n\n          -  HIV infection.\n\n          -  CD4 count <= 200 cells/mm3 or <= 15 percent of total lymphocytes OR a history of\n             prior PCP.\n\n          -  History of intolerance to trimethoprim and/or sulfonamides.\n\n          -  No active pneumocystosis. Patient or guardian must sign informed consent. Pregnant\n             patients are eligible at the clinician's discretion. Patients who do not meet\n             required laboratory values may be eligible at the discretion of the clinician.\n\n        Exclusion Criteria\n\n        Concurrent Medication:\n\n        Excluded:\n\n          -  Any medication with potential anti-PCP activity.\n\n        Patients with the following prior conditions are excluded:\n\n          -  Treatment-limiting reaction to pentamidine or dapsone."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "13 Years"
        }, 
        "enrollment": "400", 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00001028", 
            "org_study_id": "CPCRA 013", 
            "secondary_id": "11565"
        }, 
        "intervention": [
            {
                "intervention_name": "Pentamidine isethionate", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Dapsone", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Dapsone", 
                "Trimethoprim", 
                "Pentamidine"
            ]
        }, 
        "keyword": [
            "Pneumonia, Pneumocystis carinii", 
            "Pentamidine", 
            "Dapsone", 
            "Acquired Immunodeficiency Syndrome", 
            "AIDS-Related Complex"
        ], 
        "lastchanged_date": "March 28, 2012", 
        "link": {
            "description": "Click here for more information about Pentamidine isethionate", 
            "url": "http://www.aidsinfo.nih.gov/DrugsNew/DrugDetailNT.aspx?MenuItem=Drugs&Search=On&int_id=25"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94110"
                    }, 
                    "name": "Community Consortium of San Francisco"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Denver", 
                        "country": "United States", 
                        "state": "Colorado", 
                        "zip": "802044507"
                    }, 
                    "name": "Denver CPCRA / Denver Public Hlth"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wilmington", 
                        "country": "United States", 
                        "state": "Delaware", 
                        "zip": "19899"
                    }, 
                    "name": "Wilmington Hosp / Med Ctr of Delaware"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Washington", 
                        "country": "United States", 
                        "state": "District of Columbia", 
                        "zip": "20422"
                    }, 
                    "name": "Veterans Administration Med Ctr / Regional AIDS Program"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60657"
                    }, 
                    "name": "AIDS Research Alliance - Chicago"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Indianapolis", 
                        "country": "United States", 
                        "state": "Indiana", 
                        "zip": "46202"
                    }, 
                    "name": "Wishard Hosp / Indiana Univ Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Orleans", 
                        "country": "United States", 
                        "state": "Louisiana", 
                        "zip": "70112"
                    }, 
                    "name": "Louisiana Comm AIDS Rsch Prog / Tulane Univ Med"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Detroit", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48202"
                    }, 
                    "name": "Henry Ford Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Detroit", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48201"
                    }, 
                    "name": "Comprehensive AIDS Alliance of Detroit"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Newark", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "071032842"
                    }, 
                    "name": "North Jersey Community Research Initiative"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bronx", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10456"
                    }, 
                    "name": "Bronx Lebanon Hosp Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10037"
                    }, 
                    "name": "Harlem AIDS Treatment Group / Harlem Hosp Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Portland", 
                        "country": "United States", 
                        "state": "Oregon", 
                        "zip": "972109951"
                    }, 
                    "name": "Portland Veterans Adm Med Ctr / Rsch & Education Grp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Richmond", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "23298"
                    }, 
                    "name": "Richmond AIDS Consortium"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "A Randomized, Comparative, Prospective Study of Monthly Aerosolized Pentamidine and Thrice Weekly Dapsone for Prophylaxis Against PCP in HIV-Infected Patients Who Are Intolerant to Trimethoprim and/or Sulfonamides", 
        "overall_official": [
            {
                "last_name": "El-Sadr W", 
                "role": "Study Chair"
            }, 
            {
                "last_name": "Luskin-Hawk R", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 3", 
        "reference": {
            "citation": "el-Sadr W, Wentworth D, Dehlinger M, Larntz K. Design and implementation of a community-based trial for prophylaxis for P. carinii pneumonia (PCP). Int Conf AIDS. 1993 Jun 6-11;9(1):79 (abstract no WS-B36-2)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00001028"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "National Institute of Allergy and Infectious Diseases (NIAID)", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Jacobus Pharmaceutical", 
                    "agency_class": "Industry"
                }, 
                {
                    "agency": "Fujisawa Pharmaceutical Co", 
                    "agency_class": "Industry"
                }
            ], 
            "lead_sponsor": {
                "agency": "National Institute of Allergy and Infectious Diseases (NIAID)", 
                "agency_class": "NIH"
            }
        }, 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2012"
    }, 
    "geocoordinates": {
        "AIDS Research Alliance - Chicago": "41.878 -87.63", 
        "Bronx Lebanon Hosp Ctr": "40.85 -73.867", 
        "Community Consortium of San Francisco": "37.775 -122.419", 
        "Comprehensive AIDS Alliance of Detroit": "42.331 -83.046", 
        "Denver CPCRA / Denver Public Hlth": "39.739 -104.985", 
        "Harlem AIDS Treatment Group / Harlem Hosp Ctr": "40.714 -74.006", 
        "Henry Ford Hosp": "42.331 -83.046", 
        "Louisiana Comm AIDS Rsch Prog / Tulane Univ Med": "29.951 -90.072", 
        "North Jersey Community Research Initiative": "40.736 -74.172", 
        "Portland Veterans Adm Med Ctr / Rsch & Education Grp": "45.523 -122.676", 
        "Richmond AIDS Consortium": "37.541 -77.436", 
        "Veterans Administration Med Ctr / Regional AIDS Program": "38.895 -77.036", 
        "Wilmington Hosp / Med Ctr of Delaware": "39.746 -75.547", 
        "Wishard Hosp / Indiana Univ Hosp": "39.769 -86.158"
    }
}